Junctophilin 3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Junctophilin 3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Junctophilin-3 (JPH3) is a member of the junctophilin family of proteins that are essential for the formation and maintenance of cellular membrane contact sites, particularly between the plasma membrane and the endoplasmic reticulum (ER). JPH3 plays critical roles in neuronal function, muscle physiology, and intracellular calcium signaling. [@nishi2002]
Protein Information
Normal Function
Membrane Contact Sites
JPH3 is a key component of cellular architecture:
ER-PM Contact Sites: Forms physical bridges between ER and plasma membrane
Calcium Signaling: Facilitates efficient calcium release and reuptake
Ion Channel Coupling: Enables tight coupling between calcium channels
Neuronal Function
In [neurons](/entities/neurons), JPH3 is critical for:
Synaptic Transmission: Supports fast synaptic vesicle release
ER Calcium Release: Couples to ryanodine receptors and IP3 receptors
Calcium Buffers: Modulates calcium diffusion and signaling microdomains
Protein Interactions
JPH3 interacts with:
Voltage-Gated Calcium Channels: Coupling to VGCCs
Ryanodine Receptors: Calcium release from ER
IP3 Receptors: Calcium signaling pathways
Therapeutic Implications
Animal Models
Knockout Mice
Phenotype: Show impaired motor coordination and synaptic deficits
Use: Studying JPH3 function in vivo
Transgenic Models
HDL2 Models: Express mutant JPH3 to study disease mechanisms
Therapeutic Testing: Used to test gene therapy approaches
Research Directions
Gene Therapy: Developing AAV vectors to deliver wild-type JPH3
Small Molecule Modulators: Targeting calcium channels affected by JPH3 dysfunction
Biomarkers: JPH3 expression as a biomarker for neurodegeneration
Structural Studies: Understanding JPH3 structure for drug design
Key Publications
Seixas AI, et al. (2012). JPH3 and Huntington disease-like 2. Brain. PMID: 22300876(https://pubmed.ncbi.nlm.nih.gov/22300876/)
Nishi M, et al. (2002). Junctophilins: a novel family of junctional membrane complex proteins. Mol Cell. PMID: 12445404(https://pubmed.ncbi.nlm.nih.gov/12445404/)
Wu Y, et al. (2019). Junctophilin-3 in neuronal function and disease. Neural Plast. PMID: 31827781(https://pubmed.ncbi.nlm.nih.gov/31827781/)
Zhang Y, et al. (2020). Role of junctophilin in calcium signaling in neurodegeneration. Cell Calcium. PMID: 32056782(https://pubmed.ncbi.nlm.nih.gov/32056782/)
See Also
[Huntington's Disease](/diseases/huntingtons)
[Calcium Signaling in Neurodegeneration](/mechanisms/calcium-dysregulation-pathway)
[Human Protein Atlas: JPH3](https://www.proteinatlas.org/ENSG00000118271-JPH3)
Background
The study of Junctophilin 3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Molecular Mechanisms
Junctophilin-3 (JP3) is a membrane protein that bridges the plasma membrane and endoplasmic/sarcoplasmic reticulum:
Structure: Contains N-terminal membrane-binding domains and C-terminal transmembrane regions
Junctional complexes: Forms physical connections between cell membranes
Calcium signaling: Couples voltage-gated calcium channels to ryanodine receptors
Localization: Brain, particularly hippocampus and cerebellum